Targeted Delivery of Anti-Inflammatory Agents to Tumors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1825-1843
Author(s):
Maria Coimbra, Sylvia A. Kuijpers, Sebastiaan P. van Seters, Gert Storm and Raymond M. Schiffelers
III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1854-1867
Author(s):
Mitsuko Furuya, Yoshikazu Yonemitsu and Ichiro Aoki
Mast Cells as Target in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1868-1878
Author(s):
Tom Groot Kormelink, Abulikemu Abudukelimu and Frank A. Redegeld
Regulatory T Cells: Major Players in the Tumor Microenvironment
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1879-1892
Author(s):
Marc Beyer and Joachim L. Schultze
Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Journal:
Current Genomics
Volume:
10
Page:
281-293
Author(s):
E. Kirches
HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
451-468
Author(s):
Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
572-594
Author(s):
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
575-576
Author(s):
Alberto Ocana, Rosario Serrano, Raul Calero and Atanasio Pandiella
Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Journal:
Current Drug Metabolism
Volume:
10
Page:
470-481
Author(s):
Jorg Thomas Hartmann, Michael Haap, Hans-Georg Kopp and Hans-Peter Lipp
Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
113-131
Author(s):
Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti